Inhibition of SHMT2 activity leads to the reduced proliferation of squamous cell carcinoma cells [66] and prevents the growth of tumors derived from hepatoma cells in a xenograft model [67]. This evidence concerns the gene SHMT2 and hepatocellular carcinoma.